Chiara Gangemi

Chiara Gangemi

Auto-generated profile, based on publicly available information

Chiara Gangemi

Department of Biomedical Sciences and Morpho-functional Imaging, Polyclinic University of Messina, Messina, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2014 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
MCMonica Currò
Monica Currò
AGAgnese Gugliandolo
Agnese Gugliandolo
CGC. Gangemi
C. Gangemi
RRR. Risitano
R. Risitano
RIRiccardo Ientile
Riccardo Ientile
DCDaniela Caccamo
Daniela Caccamo

30 January 2015 in Free Radical Research
Verified
Journal Article
Closed access
MCMonica Currò
Monica Currò
CGC. Gangemi
C. Gangemi
AGAgnese Gugliandolo
Agnese Gugliandolo
RRR. Risitano
R. Risitano
NFN. Ferlazzo
N. Ferlazzo
DCDaniela Caccamo
Daniela Caccamo
Aberrant transglutaminase 2 (TG2) expression and protein cross-linking activity have been associated with several chronic neurodegenerative disorders in which inflammatory processes triggered by activated microglia and monocytes play a key role, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Interestingly, mild-to-moderate hyperhomocysteinemia (HHcy), corresponding to increased plasma homocysteine (Hcy) concentrations in the range 16-60 μM, have recently been associated with the above-cited diseases. Using THP-1 monocytes, here we investigated the role of TG2 in cell response to mildly elevated Hcy concentrations. A five-day incubation with Hcy (∼25 μM) increased reactive oxygen species, peroxide lipids, as well as 8-hydroxyguanosine levels by twofold, and decreased the endogenous cell antioxidant defenses, that is reduced glutathione, by 50% in Hcy-exposed cultures compared with controls (p < 0.01). Hcy-induced oxidative stress was associated with increases in TG2 expression and activity, as well as nuclear factor kappa B activation. Notably, the latter was reduced in the presence of the TG-specific inhibitor R283. Hcy exposure also significantly increased the mRNA levels of tumor necrosis factor alpha, interleukin (IL)-6, and IL-1β, as well as the level of Hcy-inducible endoplasmic reticulum (ER) stress protein, a marker of ER stress, in Hcy-exposed cultures compared with controls. Notably, these effects were dramatically reduced by R283. These preliminary findings indicate that TG2 plays a key role in Hcy-induced activation of THP-1 monocytes, involving oxidative as well as ER stress and inflammation. This underlines the potential of TG2 inhibition in the therapeutic management of inflammatory processes contributing to neurodegenerative disorders associated with mild HHcy.

1 May 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GPGianluca Pandolfo
Gianluca Pandolfo
AGAgnese Gugliandolo
Agnese Gugliandolo
CGC. Gangemi
C. Gangemi
RAR. Arrigo
R. Arrigo
MCMonica Currò
Monica Currò
DCDaniela Caccamo
Daniela Caccamo

1 January 2016 in Biomedical Genetics and Genomics
Verified
Journal Article
Open access
Antonio BrunoAntonio Bruno
Antonio Bruno
CGChiara Gangemi
Chiara Gangemi
AGAgnese Gugliandolo
Agnese Gugliandolo
MCManuela Crucitti
Manuela Crucitti
MCMonica Currò
Monica Currò
MMMaria R.A. Muscatello
Maria R.A. Muscatello